Renal Sodium - Glucose Cotransporter Inhibition in the Management of Type 2 Diabetes 2 Mellitus 3
نویسندگان
چکیده
Revised 8-19-2015 (LOA) 1 Renal Sodium-Glucose Cotransporter Inhibition in the Management of Type 2 Diabetes 2 Mellitus 3 Muhammad A Abdul-Ghani, MD, PhD, Luke Norton, Ph.D., and Ralph A DeFronzo, MD 4 Division of Diabetes, University of Texas Health Science Center at San Antonio, Texas, USA 5 6
منابع مشابه
Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes
Type 2 diabetes mellitus (T2DM) is a growing worldwide epidemic. Patients face lifelong therapy to control hyperglycemia and prevent the associated complications. There are many medications, with varying mechanisms, available for the treatment of T2DM, but almost all target the declining insulin sensitivity and secretion that are associated with disease progression. Medications with such insuli...
متن کاملRenal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus.
Hyperglycemia is the primary factor responsible for the microvascular, and to a lesser extent macrovascular, complications of diabetes. Despite this well-established relationship, approximately half of all type 2 diabetic patients in the US have a hemoglobin A1c (HbA1c) ≥7.0%. This is associated in part with the side effects, i.e., weight gain and hypoglycemia, of currently available antidiabet...
متن کاملRenal threshold for glucose reabsorption predicts diabetes improvement by sodium‐glucose cotransporter 2 inhibitor therapy
In the present study we examined the efficacy of sodium-glucose cotransporter 2 inhibitors on improvement of glycated hemoglobin (HbA1c) in comparison with the renal threshold for glucose reabsorption in patients with type 2 diabetes mellitus. Patients visited the hospital once a month for a regular follow-up examination with the determination of blood glucose and HbA1c levels, and urinary gluc...
متن کاملSGLT2 Inhibitors: A New Generation of Antidiabetic Drugs
The incidence of type 2 diabetes is markedly increasing worldwide. Despite a plethora of therapeutic options available for the treatment of type 2 diabetes, the ability to effectively normalize blood glucose levels and prevent long-term complications of diabetes remains elusive. There is intense search for new drugs for diabetes. One novel therapeutic class of antidiabetic drugs is sodium-gluco...
متن کاملSGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors1
Background: Sodium glucose cotransporter-2 (SGLT2) inhibitors are recommended by the American Diabetes Association (ADA) for the treatment of type 2 diabetes as one of six second-line therapy options after initial therapy with metformin. In addition, they have been studied in combination with insulin as a potential option for treating patients with type 1 diabetes. These medications act by inhi...
متن کامل